Clinical characteristics and outcomes in patients with COVID-19 and leprosy

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e1-e2. doi: 10.1111/jdv.16899. Epub 2020 Oct 21.

Authors

V S Santos¹, L J Quintans-Júnior², W S Barboza³, A A de S Araújo², P R Martins-Filho^{2

4}

Affiliations

¹ Centre for Epidemiology and Public Health, Federal University of Alagoas, Arapiraca, Brazil.
² Graduate Program in Health Science. Federal University of Sergipe, Aracaju, Brazil.
³ Health Bureau of Aracaju, Aracaju, Brazil.
⁴ Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, Brazil.

PMID: 32865267
DOI: 10.1111/jdv.16899

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Brazil / epidemiology
COVID-19 / complications*
COVID-19 / epidemiology
Coinfection / mortality*
Comorbidity
Databases, Factual
Diabetes Mellitus / epidemiology
Female
Humans
Hypertension / epidemiology
Length of Stay
Leprosy, Lepromatous / complications*
Leprosy, Lepromatous / epidemiology
Male
Middle Aged
SARS-CoV-2